SHUKRA PHARMACEUTICALS
|
SHUKRA PHARMACEUTICALS Last 5 Year Balance Sheet History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| EQUITY AND LIABILITIES | |||||
| Share Capital | ₹44 Cr | ₹11 Cr | ₹3.91 Cr | ₹1.57 Cr | ₹1.57 Cr |
| Equity - Authorised | ₹49 Cr | ₹12 Cr | ₹12 Cr | ₹12 Cr | ₹12 Cr |
| Equity - Issued | ₹44 Cr | ₹11 Cr | ₹11 Cr | ₹1.57 Cr | ₹1.57 Cr |
| Equity Paid Up | ₹44 Cr | ₹11 Cr | ₹3.91 Cr | ₹1.57 Cr | ₹1.57 Cr |
| Equity Shares Forfeited | - | ₹0.00 Cr | - | - | - |
| Adjustments to Equity | - | - | - | - | - |
| Preference Capital Paid Up | - | - | - | - | - |
| Face Value | ₹1.00 | ₹10.00 | ₹10.00 | ₹10.00 | ₹10.00 |
| Share Warrants & Outstandings | - | - | - | - | - |
| Total Reserves | ₹19 Cr | ₹47 Cr | ₹21 Cr | ₹15 Cr | ₹14 Cr |
| Securities Premium | ₹4.74 Cr | ₹9.12 Cr | ₹2.28 Cr | - | - |
| Capital Reserves | ₹0.01 Cr | ₹0.01 Cr | - | - | - |
| Profit & Loss Account Balance | ₹14 Cr | ₹38 Cr | ₹19 Cr | ₹15 Cr | ₹14 Cr |
| General Reserves | - | - | - | - | - |
| Other Reserves | - | - | ₹-0.01 Cr | - | - |
| Reserve excluding Revaluation Reserve | ₹19 Cr | ₹47 Cr | ₹21 Cr | ₹15 Cr | ₹14 Cr |
| Revaluation reserve | - | - | - | - | - |
| Shareholder's Funds | ₹63 Cr | ₹58 Cr | ₹25 Cr | ₹16 Cr | ₹16 Cr |
| Minority Interest | - | - | - | - | - |
| Long-Term Borrowings | - | - | - | - | - |
| Secured Loans | ₹1.64 Cr | ₹1.25 Cr | ₹0.90 Cr | ₹0.85 Cr | ₹0.66 Cr |
| Non Convertible Debentures | - | - | - | - | - |
| Converible Debentures & Bonds | - | - | - | - | - |
| Packing Credit - Bank | - | - | - | - | - |
| Inter Corporate & Security Deposit | - | - | - | - | - |
| Term Loans - Banks | ₹2.60 Cr | ₹1.38 Cr | ₹1.10 Cr | ₹0.99 Cr | ₹0.66 Cr |
| Term Loans - Institutions | - | - | - | - | - |
| Other Secured | ₹-0.96 Cr | ₹-0.13 Cr | ₹-0.21 Cr | ₹-0.14 Cr | - |
| Unsecured Loans | ₹1.48 Cr | ₹1.41 Cr | ₹2.87 Cr | ₹2.28 Cr | ₹9.11 Cr |
| Fixed Deposits - Public | - | - | - | - | - |
| Loans and advances from subsidiaries | - | - | - | - | - |
| Inter Corporate Deposits (Unsecured) | - | - | - | - | - |
| Foreign Currency Convertible Notes | - | - | - | - | - |
| Long Term Loan in Foreign Currency | - | - | - | - | - |
| Loans - Banks | - | - | - | - | - |
| Loans - Govt. | - | - | - | - | - |
| Loans - Others | ₹1.48 Cr | ₹1.41 Cr | ₹2.87 Cr | ₹2.28 Cr | ₹9.11 Cr |
| Other Unsecured Loan | - | - | - | - | - |
| Deferred Tax Assets / Liabilities | ₹3.41 Cr | ₹3.27 Cr | ₹3.29 Cr | ₹3.26 Cr | ₹3.20 Cr |
| Deferred Tax Assets | - | ₹0.02 Cr | - | - | - |
| Deferred Tax Liability | ₹3.41 Cr | ₹3.29 Cr | ₹3.29 Cr | ₹3.26 Cr | ₹3.20 Cr |
| Other Long Term Liabilities | - | - | - | - | - |
| Long Term Trade Payables | - | - | - | - | - |
| Long Term Provisions | ₹0.13 Cr | ₹0.12 Cr | ₹0.11 Cr | - | - |
| Total Non-Current Liabilities | ₹6.65 Cr | ₹6.04 Cr | ₹7.16 Cr | ₹6.39 Cr | ₹13 Cr |
| Current Liabilities | - | - | - | - | - |
| Trade Payables | ₹9.22 Cr | ₹7.22 Cr | ₹34 Cr | ₹8.59 Cr | ₹5.33 Cr |
| Sundry Creditors | ₹9.22 Cr | ₹7.22 Cr | ₹34 Cr | ₹8.59 Cr | ₹5.33 Cr |
| Acceptances | - | - | - | - | - |
| Due to Subsidiaries- Trade Payables | - | - | - | - | - |
| Other Current Liabilities | ₹5.09 Cr | ₹6.03 Cr | ₹8.78 Cr | ₹3.47 Cr | ₹0.94 Cr |
| Bank Overdraft / Short term credit | - | - | - | - | - |
| Advances received from customers | ₹2.64 Cr | ₹3.53 Cr | ₹6.61 Cr | ₹2.47 Cr | ₹0.85 Cr |
| Interest Accrued But Not Due | - | - | - | ₹0.01 Cr | - |
| Share Application Money | - | - | - | - | - |
| Current maturity of Debentures & Bonds | - | - | - | - | - |
| Current maturity - Others | - | - | - | - | - |
| Other Liabilities | ₹2.45 Cr | ₹2.50 Cr | ₹2.17 Cr | ₹1.00 Cr | ₹0.09 Cr |
| Short Term Borrowings | - | - | - | - | - |
| Secured ST Loans repayable on Demands | - | - | - | - | - |
| Working Capital Loans- Sec | - | - | - | - | - |
| Buyers Credits - Unsec | - | - | - | - | - |
| Commercial Borrowings- Unsec | - | - | - | - | - |
| Other Unsecured Loans | - | - | - | - | - |
| Short Term Provisions | ₹2.97 Cr | ₹0.90 Cr | ₹0.10 Cr | ₹0.32 Cr | ₹0.77 Cr |
| Proposed Equity Dividend | ₹0.09 Cr | ₹0.03 Cr | ₹0.04 Cr | ₹0.04 Cr | ₹0.05 Cr |
| Provision for Corporate Dividend Tax | - | - | - | - | - |
| Provision for Tax | - | - | - | - | ₹0.03 Cr |
| Provision for post retirement benefits | - | - | ₹0.03 Cr | ₹0.28 Cr | ₹0.00 Cr |
| Preference Dividend | - | - | - | - | - |
| Other Provisions | ₹2.89 Cr | ₹0.87 Cr | ₹0.03 Cr | - | ₹0.69 Cr |
| Total Current Liabilities | ₹17 Cr | ₹14 Cr | ₹43 Cr | ₹12 Cr | ₹7.04 Cr |
| Total Liabilities | ₹87 Cr | ₹78 Cr | ₹75 Cr | ₹35 Cr | ₹36 Cr |
| ASSETS | |||||
| Gross Block | ₹43 Cr | ₹41 Cr | ₹40 Cr | ₹35 Cr | ₹34 Cr |
| Less: Accumulated Depreciation | ₹24 Cr | ₹21 Cr | ₹19 Cr | ₹18 Cr | ₹16 Cr |
| Less: Impairment of Assets | - | - | - | - | - |
| Net Block | ₹19 Cr | ₹20 Cr | ₹20 Cr | ₹18 Cr | ₹18 Cr |
| Lease Adjustment A/c | - | - | - | - | - |
| Capital Work in Progress | ₹1.95 Cr | ₹1.66 Cr | ₹1.66 Cr | ₹1.66 Cr | ₹1.66 Cr |
| Non Current Investments | - | - | - | - | ₹0.20 Cr |
| Long Term Investment | - | - | - | - | ₹0.20 Cr |
| Quoted | - | - | - | - | - |
| Unquoted | - | - | - | - | ₹0.20 Cr |
| Long Term Loans & Advances | - | - | - | - | - |
| Other Non Current Assets | - | - | - | - | - |
| Total Non-Current Assets | ₹21 Cr | ₹22 Cr | ₹22 Cr | ₹19 Cr | ₹20 Cr |
| Current Assets Loans & Advances | - | - | - | - | - |
| Currents Investments | - | - | - | - | - |
| Quoted | - | - | - | - | - |
| Unquoted | - | - | - | - | - |
| Inventories | ₹9.95 Cr | ₹2.31 Cr | ₹3.16 Cr | ₹3.95 Cr | ₹1.68 Cr |
| Raw Materials | ₹5.24 Cr | ₹1.23 Cr | ₹1.37 Cr | ₹2.50 Cr | ₹0.96 Cr |
| Work-in Progress | ₹2.07 Cr | ₹1.09 Cr | ₹1.79 Cr | ₹1.45 Cr | ₹0.68 Cr |
| Finished Goods | ₹2.65 Cr | - | - | - | - |
| Packing Materials | - | - | - | - | ₹0.04 Cr |
| Stores  and Spare | - | - | - | - | - |
| Other Inventory | - | - | - | - | - |
| Sundry Debtors | ₹8.77 Cr | ₹25 Cr | ₹30 Cr | ₹7.40 Cr | ₹9.75 Cr |
| Debtors more than Six months | ₹0.94 Cr | ₹6.30 Cr | ₹1.21 Cr | ₹2.06 Cr | ₹0.30 Cr |
| Debtors Others | ₹7.82 Cr | ₹18 Cr | ₹29 Cr | ₹5.34 Cr | ₹9.45 Cr |
| Cash and Bank | ₹12 Cr | ₹9.98 Cr | ₹3.97 Cr | ₹0.29 Cr | ₹0.50 Cr |
| Cash in hand | ₹0.40 Cr | ₹0.17 Cr | ₹0.04 Cr | ₹0.05 Cr | ₹0.28 Cr |
| Balances at Bank | ₹12 Cr | ₹9.82 Cr | ₹3.94 Cr | ₹0.24 Cr | ₹0.23 Cr |
| Other cash and bank balances | - | - | - | - | - |
| Other Current Assets | ₹19 Cr | ₹6.19 Cr | ₹7.97 Cr | ₹0.17 Cr | ₹0.14 Cr |
| Interest accrued on Investments | - | - | - | - | - |
| Interest accrued on Debentures | - | - | - | - | - |
| Deposits with Government | - | - | - | - | - |
| Interest accrued and or due on loans | - | - | - | - | - |
| Prepaid Expenses | ₹0.01 Cr | ₹0.02 Cr | ₹0.02 Cr | ₹0.06 Cr | ₹0.03 Cr |
| Other current_assets | ₹19 Cr | ₹6.17 Cr | ₹7.95 Cr | ₹0.11 Cr | ₹0.11 Cr |
| Short Term Loans and Advances | ₹16 Cr | ₹13 Cr | ₹7.79 Cr | ₹4.06 Cr | ₹3.98 Cr |
| Advances recoverable in cash or in kind | ₹4.19 Cr | ₹10 Cr | ₹4.85 Cr | ₹0.94 Cr | ₹0.52 Cr |
| Advance income tax and TDS | ₹0.72 Cr | ₹0.34 Cr | ₹0.26 Cr | ₹0.57 Cr | - |
| Amounts due from directors | - | - | - | - | - |
| Due From Subsidiaries | - | - | - | - | - |
| Inter corporate deposits | - | - | - | - | - |
| Corporate Deposits | - | - | - | - | - |
| Other Loans & Advances | ₹11 Cr | ₹2.45 Cr | ₹2.67 Cr | ₹2.55 Cr | ₹3.46 Cr |
| Total Current Assets | ₹65 Cr | ₹56 Cr | ₹53 Cr | ₹16 Cr | ₹16 Cr |
| Net Current Assets (Including Current Investments) | ₹48 Cr | ₹42 Cr | ₹11 Cr | ₹3.50 Cr | ₹9.03 Cr |
| Miscellaneous Expenses not written off | - | - | - | - | - |
| Total Assets | ₹87 Cr | ₹78 Cr | ₹75 Cr | ₹35 Cr | ₹36 Cr |
| Contingent Liabilities | ₹1.40 Cr | ₹1.40 Cr | - | ₹1.40 Cr | - |
| Total Debt | ₹4.18 Cr | ₹3.15 Cr | ₹5.08 Cr | ₹3.38 Cr | ₹9.77 Cr |
| Book Value | 1.44 | 52.67 | 64.63 | 104.43 | 99.63 |
| Adjusted Book Value | 1.44 | 1.32 | 1.62 | 0.54 | 0.52 |
Compare Balance Sheet of peers of SHUKRA PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SHUKRA PHARMACEUTICALS | ₹1,940.3 Cr | 8.2% | 23.8% | 528.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹423,171.0 Cr | 2.8% | 6.6% | -2.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹173,172.0 Cr | -0.2% | -0.7% | 10.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹129,176.0 Cr | -0.2% | 8.1% | 21.8% | Stock Analytics | |
| CIPLA | ₹124,094.0 Cr | 1.4% | -1.4% | -1.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,869.0 Cr | 2.7% | 1% | -3.4% | Stock Analytics | |
SHUKRA PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SHUKRA PHARMACEUTICALS | 8.2% |
23.8% |
528.3% |
| SENSEX | 1.7% |
3.6% |
6.9% |
You may also like the below Video Courses